|
EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]-furan-2-carboxamide (furanylfentanyl) |
2017 |
Joint Reports |
English |
|
High-risk drug use and new psychoactive substances |
2017 |
Rapid communication |
English |
|
Report on the risk assessment of methyl 2-[[1-(cyclohexylmethyl)-1H-indole-3-carbonyl]amino]-3,3-dimethylbutanoate (MDMB-CHMICA) in the framework of the Council Decision on new psychoactive substances |
2017 |
Risk assessments |
English |
|
EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl) |
2017 |
Joint Reports |
English |
|
New psychoactive substances in Europe: legislation and prosecution — current challenges and solutions |
2016 |
Joint publications |
English |
|
Report on the risk assessment of 1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (α-pyrrolidinovalerophenone, α-PVP) |
2016 |
Risk assessments |
English |
|
EMCDDA–Europol 2015 Annual Report on the implementation of Council Decision 2005/387/JHA |
2016 |
Implementation reports |
English |
|
EMCDDA–Europol Joint Report on MDMB-CHMICA |
2016 |
Joint Reports |
English |
|
Health responses to new psychoactive substances |
2016 |
Rapid communication |
English |
|
Health responses to new psychoactive substances (Perspectives on Drugs) |
2016 |
Perspectives on Drugs (PODs) |
English |
|
Legal approaches to controlling new psychoactive substances (Perspectives on drugs) |
2016 |
Perspectives on Drugs (PODs) |
English |
|
Report on the risk assessment of MT-45 in the framework of the Council Decision on new psychoactive substances |
2015 |
Risk assessments |
English |
|
Report on the risk assessment of 4,4′-DMAR in the framework of the Council Decision on new psychoactive substances |
2015 |
Risk assessments |
English |
|
New psychoactive substances in Europe: Innovative legal responses |
2015 |
Rapid communication |
English |
|
European Drug Report 2015: Trends and Developments |
2015 |
European Drug Report |
English Spanish Estonian Finnish French Croatian Hungarian Italian Lithuanian Latvian Dutch Norwegian Polish Portuguese Romanian Slovakian Slovene Swedish Turkish Bulgarian Czech Danish German Greek |
|
New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015) |
2015 |
Rapid communication |
English |
|
New psychoactive substances in Europe (poster) |
2015 |
Poster |
English |
|
EMCDDA–Europol Joint Report on a new psychoactive substance: 1-cyclohexyl-4-(1,2-diphenylethyl)piperazine (‘MT-45’) |
2014 |
Joint Reports |
English |
|
EMCDDA–Europol Joint Report on a new psychoactive substance: 4,4'-DMAR (4-methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine) |
2014 |
Joint Reports |
English |
|
EMCDDA–Europol 2013 Annual Report on the implementation of Council Decision 2005/387/JHA |
2014 |
Implementation reports |
English |
|
Report on the risk assessment of 2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl)ethanamine (25I-NBOMe) in the framework of the Council Decision on new psychoactive substances |
2014 |
Risk assessments |
English |
|
Report on the risk assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (MDPV) in the framework of the Council Decision on new psychoactive substances |
2014 |
Risk assessments |
English |
|
Report on the risk assessment of 3,4-dichloro-N-{[1-(dimethylamino)cyclohexyl]methyl}benzamide (AH-7921) in the framework of the Council Decision on new psychoactive substances |
2014 |
Risk assessments |
English |
|
Report on the risk assessment of 2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone (methoxetamine) in the framework of the Council Decision on new psychoactive substances |
2014 |
Risk assessments |
English |
|
European Drug Report 2014: Trends and developments |
2014 |
European Drug Report |
English Spanish Estonian Finnish French Croatian Hungarian Italian Lithuanian Latvian Dutch Norwegian Polish Portuguese Romanian Slovakian Slovene Swedish Portuguese Bulgarian Czech Danish German Greek |
|
Emergency health consequences of cocaine use in Europe. A review of the monitoring of drug-related acute emergencies in 30 European countries |
2014 |
Technical reports |
English |
|
Drugnet Europe 85 |
2014 |
Drugnet Europe |
English |
|
EMCDDA–Europol Joint Report on a new psychoactive substance: AH-7921 |
2014 |
Joint Reports |
English |
|
EMCDDA–Europol Joint Report on a new psychoactive substance: 25I-NBOMe |
2014 |
Joint Reports |
English |
|
EMCDDA–Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone) |
2014 |
Joint Reports |
English |
|
EMCDDA–Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone) |
2014 |
Joint Reports |
English |
|
Report on the risk assessment of 5-(2-aminopropyl)indole in the framework of the Council Decision on new psychoactive substances |
2014 |
Risk assessments |
English |
|
Report on the risk assessment of 4-methylamphetamine in the framework of the Council Decision on new psychoactive substances |
2014 |
Risk assessments |
English |
|
Drugnet Europe 84 |
2013 |
Drugnet Europe |
English |
|
EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012) |
2013 |
Implementation reports |
English |
|
European Drug Report 2013: Trends and developments |
2013 |
European Drug Report |
Bulgarian Czech Danish German Greek English Spanish Estonian Finnish French Croatian Hungarian Italian Lithuanian Latvian Dutch Norwegian Polish Portuguese Romanian Slovakian Slovene Swedish |
|
Drugnet Europe 81 |
2013 |
Drugnet Europe |
English |
|
EMCDDA–Europol Joint Report on a new psychoactive substance: 5-(2-aminopropyl)indole |
2013 |
Joint Reports |
English |
|
EU drug markets report: a strategic analysis |
2013 |
Joint publications |
English |
|
EMCDDA–Europol Joint Report on a new psychoactive substance: 4-methylamphetamine |
2012 |
Joint Reports |
English |
|
Drugnet Europe 78 |
2012 |
Drugnet Europe |
English |
|
Early warning system — national profiles |
2012 |
Thematic papers |
English |
|
EMCDDA–Europol 2011 Annual Report on the implementation of Council Decision 2005/387/JHA |
2012 |
Implementation reports |
English |
|
EMCDDA trend report for the evaluation of the 2005–12 EU drugs strategy |
2012 |
Ad hoc publication |
English |
|
Drugnet Europe 77 |
2012 |
Drugnet Europe |
English |
|
Responding to new psychoactive substances |
2011 |
Drugs in focus |
Bulgarian Spanish Czech Danish German Estonian Greek English French Irish Italian Latvian Dutch Hungarian Maltese Dutch Polish English Romanian Slovakian Slovene Finnish Swedish Turkish Norwegian |
|
Drugnet Europe 76 |
2011 |
Drugnet Europe |
English |
|
Online sales of new psychoactive substances / 'legal highs': summary of results from the 2011 multilingual snapshots |
2011 |
Technical reports |
English |
|
EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA |
2011 |
Implementation reports |
English |
|
Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances |
2011 |
Risk assessments |
English |
|
2010 Annual report on the state of the drugs problem in Europe |
2010 |
European Drug Report |
Bulgarian Spanish Czech Danish German Estonian Greek English French Italian Latvian Lithuanian Hungarian Dutch Polish Portuguese Romanian Slovakian Slovene Finnish Swedish Norwegian |
|
EMCDDA–Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA |
2010 |
Implementation reports |
English |
|
Risk assessment of new psychoactive substances — operating guidelines |
2010 |
Risk assessments |
English |
|
Europol–EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone) |
2010 |
Joint Reports |
English |
|
Understanding the 'Spice' phenomenon |
2009 |
Thematic papers |
English |
|
2009 Annual report on the state of the drugs problem in Europe |
2009 |
European Drug Report |
Bulgarian Czech Danish German Greek English Spanish Estonian Finnish French Hungarian Italian Lithuanian Latvian Dutch Norwegian Polish Portuguese Romanian Slovakian Slovene Swedish Turkish |
|
EMCDDA–Europol 2008 Annual Report on the implementation of Council Decision 2005/387/JHA |
2009 |
Implementation reports |
English |
|
EMCDDA-Europol cooperation: Joint publications on illicit drugs |
2009 |
Brochures |
English |
|
Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances |
2009 |
Risk assessments |
English |
|
EMCDDA–Europol 2007 Annual Report on the implementation of Council Decision 2005/387/JHA |
2008 |
Implementation reports |
English |
|
GHB and its precursor GBL: an emerging trend case study |
2008 |
Thematic papers |
English |
|
Early-warning system on new psychoactive substances — operating guidelines |
2007 |
Risk assessments |
English |
|
EMCDDA–Europol 2006 Annual Report on the implementation of Council Decision 2005/387/JHA |
2007 |
Implementation reports |
English |
|
Europol–EMCDDA Joint Report on a new psychoactive substance: 1-benzylpiperazine (BZP) |
2007 |
Joint Reports |
English |
|
Hallucinogenic mushrooms |
2006 |
Thematic papers |
English |
|
EMCDDA–Europol 2005 Annual Report on the implementation of Council Decision 2005/387/JHA |
2006 |
Implementation reports |
English |
|
Monitoring new drugs |
2006 |
Brochures |
English |
|
Europol–EMCDDA Joint report on a new psychoactive substance: 1-(3-chlorophenyl) piperazine (mCPP) |
2005 |
Joint Reports |
English |
|
Report on the risk assessment of TMA-2 in the framework of the joint action on new synthetic drugs |
2004 |
Risk assessments |
English |
|
Report on the risk assessment of 2C-I, 2C-T-2 and 2C-T-7 in the framework of the joint action on new synthetic drugs |
2004 |
Risk assessments |
English |
|
Report on the risk assessment of PMMA in the framework of the joint action on new synthetic drugs |
2003 |
Risk assessments |
English |
|
Polydrug use |
2002 |
Selected issues |
Spanish Danish German Greek English French Italian Dutch English Finnish Swedish Norwegian |
|
Report on the risk assessment of ketamine in the framework of the joint action on new synthetic drugs |
2002 |
Risk assessments |
English |
|
Report on the risk assessment of GHB in the framework of the joint action on new synthetic drugs |
2002 |
Risk assessments |
English |
|
Synthetic drugs |
2001 |
Selected issues |
Spanish Danish German Greek English French Italian Dutch Portuguese Finnish Swedish Norwegian |
|
Understanding and responding to drug use: the role of qualitative research |
2000 |
Monographs |
English |
|
Report on the risk assessment of 4-MTA in the framework of the joint action on new synthetic drugs |
1999 |
Risk assessments |
English |
|
Guidelines for the risk assessment of new synthetic drugs |
1999 |
Risk assessments |
English |
|
Report on the risk assessment of MBDB in the framework of the joint action on new synthetic drugs |
1999 |
Risk assessments |
English |
Belgium
Bulgaria
